FUNI - Hypha Labs, Inc.

NYSE * Healthcare * Diagnostics & Research

$0.03

+$0.00 (+0.00%)

About Hypha Labs, Inc.

Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

FUNI Key Statistics

Market Cap

$5.04M

0

P/B Ratio

11.43

EPS

$-0.01

Employees

5

How FUNI Compares to Peers

FUNI is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

#6

of 6

CompanyP/EGrowthCompare
FUNIN/A0%-
UNH23.90%vs UNH
JNJ21.30%vs JNJ
LLY39.30%vs LLY
PFE20.0-0%vs PFE
ABBV88.60%vs ABBV

Hypha Labs, Inc. Company Information

Headquarters
5940 S. Rainbow Boulevard, Las Vegas, NV, United States, 89118, undefined
Website
hyphalabs.com
Sector
Healthcare
Industry
Diagnostics & Research
Data Updated:
Ready to invest in FUNI?

Commission-free trading available. Affiliate links.

FUNI Lician Score

5% confidence
4.0/10
Neutral

FUNI has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates FUNIacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

FUNI Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

35810Value5.0Growth2.0Quality5.0Momentum5.0Safety5.04.4/10
5.0

Value

2.0

Growth

5.0

Quality

5.0

Momentum

5.0

Safety

Upcoming Events for FUNI